| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 01/28/2010 | WO2009134856A3 Pharmaceutical gallium compounds, composition and methods of preparation |
| 01/28/2010 | US20100022783 Cyclohexanecarboxylic acid compound |
| 01/28/2010 | US20100022657 Treatment of faecal incontinence and other conditions with 1R, 2S-methoxamine |
| 01/28/2010 | US20100022656 Optically active phenylethanol amines and preparing method thereof |
| 01/28/2010 | US20100022571 Substituted pyrazolo [3,4-b]pyridines as phosphodiesterase inhibitors |
| 01/28/2010 | US20100022568 Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis |
| 01/28/2010 | US20100022536 Inhibitors of Cytosolic Phospholipase A2 |
| 01/28/2010 | US20100022496 Galenical form for the administration of active ingredients by transmucous means |
| 01/28/2010 | US20100022493 Use of mometasone furoate for treating airway passage and lung disease |
| 01/28/2010 | US20100022491 4-hydroxy-2-oxo-2,3-dihydro-1,3-benzothiazol-7yl compounds for modulation of b2-adrenoreceptor activity |
| 01/28/2010 | US20100022470 Method for treating allergic diseases |
| 01/28/2010 | US20100022016 Polyamide nucleic acid derivatives and agents, and processes for preparing them |
| 01/28/2010 | US20100021547 Pharmaceutical composition for piperidinoalkanol compounds |
| 01/28/2010 | US20100021542 Extended release oral dosage composition |
| 01/28/2010 | US20100021504 Treatment and prevention of allergic airways diseases |
| 01/28/2010 | US20100021476 High Affinity Human Antibodies to Human IL-4 Receptor |
| 01/28/2010 | US20100021459 Polypeptide constructs for intracellular delivery |
| 01/28/2010 | US20100021432 Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells with a Virus |
| 01/28/2010 | US20100021431 Agent for Promoting the Production of Thioredoxin |
| 01/27/2010 | EP2147675A1 Agent for stimulating lymphatic drainage |
| 01/27/2010 | EP2147673A1 Modulation of prostaglandin/cyclooxygenase metabolic pathways |
| 01/27/2010 | EP2146988A1 New 4,8-diphenyl-polyazanaphthalene derivatives |
| 01/27/2010 | EP2146971A1 Novel benzamidine derivatives useful as potassium channel modulators |
| 01/27/2010 | EP2146957A1 Quaternary ammonium compounds useful as muscarinic receptor antagonists |
| 01/27/2010 | EP2069020B1 Benzo[d]isoxazole derivatives as c-kit tyrosine kinase inhibitors for the treatment of disorders associated with the over production of histamine |
| 01/27/2010 | EP1438298B1 Piperazine derivatives with ccr1 receptor antagonist activity |
| 01/27/2010 | EP1362106B1 Streptococcus pyogenes polypeptides and corresponding dna fragments |
| 01/27/2010 | CN101632669A Method of using diketopiperazines and composition containing them |
| 01/27/2010 | CN100584842C Thiazole derivative |
| 01/27/2010 | CN100584828C New 5-hydroxy indole-3- carboxylic esters derivative |
| 01/27/2010 | CN100584346C Method for the production of a storage-stable ivy leaf extract, and extract produced according to said method |
| 01/27/2010 | CN100584324C Use of camostat in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) |
| 01/27/2010 | CN100584318C Sugar-free type red tangerine peel granular agent for treating productive cough |
| 01/27/2010 | CN100584316C Sugar-free type red tangerine peel oral liquor for treating productive cough |
| 01/26/2010 | US7652144 Compounds as PDE IV and TNF inhibitors |
| 01/26/2010 | US7652138 Anticholinergics, processes for preparing them and pharmaceutical composition containing them |
| 01/26/2010 | US7652054 Gastrointestinal disorders; cardiovascular disorders; dyspepsia;anticancer agents; antiulcer agents |
| 01/26/2010 | US7652030 Acidic aqueous solution containing ipratropium and xylometazoline |
| 01/26/2010 | US7652022 N-(4-(4-(4-hydroxyphenylamino)-pyrimidin-6-yl)-oxyphenyl)-N'-(3-trifluoromethylphenyl)-urea; |
| 01/26/2010 | US7650733 Method and apparatus for loading a container with a product |
| 01/26/2010 | CA2529374C Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals |
| 01/26/2010 | CA2481012C Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 01/26/2010 | CA2470064C Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 01/26/2010 | CA2456606C 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 01/26/2010 | CA2338854C Nitric esters and nitrate salts of specific drugs |
| 01/21/2010 | WO2010009288A1 Compositions and uses of antiviral active pharmaceutical agents |
| 01/21/2010 | WO2010009069A1 Chromene modulators of chemokine receptor activity |
| 01/21/2010 | WO2010009068A2 Cyclohexenyl modulators of chemokine receptor activity |
| 01/21/2010 | WO2010008843A1 Apoptosis signal-regulating kinase 1 inhibitors |
| 01/21/2010 | WO2010008733A2 Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use |
| 01/21/2010 | WO2010008341A1 A combination of (a) glucocorticoid receptor modulator and (b) a muscarinic antagonist |
| 01/21/2010 | WO2010007972A1 Novel indole derivative having carbamoyl group, ureide group and substituted oxy group |
| 01/21/2010 | WO2010007756A1 Pyridine derivative having ttk inhibition activity |
| 01/21/2010 | WO2010007561A1 Novel compounds active as muscarinic receptor antagonists |
| 01/21/2010 | WO2010007427A1 Pyrimidyl sulfonaminde derivative and its use for the treatment of chemokine mediated diseases |
| 01/21/2010 | WO2010007361A1 Metered dose inhaler |
| 01/21/2010 | WO2010007316A2 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 01/21/2010 | WO2010007034A1 Use of pyrimidylaminobenzamide derivatives for the treatment of fibrosis |
| 01/21/2010 | WO2010006944A1 Aminotetrahydroindazoloacetic acids |
| 01/21/2010 | WO2010006704A1 Oxazolopyrimidines as edg-1 receptor agonists |
| 01/21/2010 | WO2009145989A3 Aminoalkylphenyl antagonists of prostaglandin d2 receptors |
| 01/21/2010 | WO2009120885A3 Stabilizing lipid compositions for oral pharmaceutical agents |
| 01/21/2010 | WO2009120799A9 Methods of treating fibrotic disorders |
| 01/21/2010 | WO2009112677A3 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 01/21/2010 | US20100016557 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha |
| 01/21/2010 | US20100016400 Azabicyclic muscarinic receptor antagonists |
| 01/21/2010 | US20100016391 Isoxazoline Compounds Having MIF Antagonist Activity |
| 01/21/2010 | US20100016388 Salts of a Selective Beta-2 Andrenoceptor Agonist |
| 01/21/2010 | US20100016386 Selective glycosidase inhibitors and uses thereof |
| 01/21/2010 | US20100016357 Use of Beta-Aminoalcohols for the Treatment of Inflammatory Disorders and Pain |
| 01/21/2010 | US20100016345 Pyrimidinyl sulfonamide compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 01/21/2010 | US20100016344 Amino heterocyclic linked pyrimidine derivatives |
| 01/21/2010 | US20100016323 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 01/21/2010 | US20100016280 Low Dosage Serotonin 5-HT2A Receptor Agonist To Suppress Inflammation |
| 01/21/2010 | US20100016239 Heparin binding motif and use thereof |
| 01/21/2010 | US20100016216 Adiponectin and uses thereof |
| 01/21/2010 | US20100015238 Powder Compositions for Inhalation |
| 01/21/2010 | US20100015225 Solid dispersion of a neurokinin antagonist |
| 01/21/2010 | US20100015149 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases |
| 01/21/2010 | US20100015121 Inhibiting gs-fdh to modulate no bioactivity |
| 01/21/2010 | US20100015062 Method of treating pulmonary disease with interferons |
| 01/21/2010 | US20100015061 Pharmaceutical Compositions Based on Anticholinergics and Andolast |
| 01/21/2010 | CA2734135A1 Metered dose inhaler |
| 01/21/2010 | CA2730959A1 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 01/21/2010 | CA2730843A1 Oxazolopyrimidines as edg-1 receptor agonists |
| 01/21/2010 | CA2730477A1 Pyrimidyl sulfonaminde derivative and its use for the treatment of chemokine mediated diseases |
| 01/21/2010 | CA2730390A1 Aminotetrahydroindazoloacetic acids |
| 01/21/2010 | CA2730281A1 Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group |
| 01/21/2010 | CA2730225A1 Use of pyrimidylaminobenzamide derivatives for the treatment of fibrosis |
| 01/21/2010 | CA2728094A1 Solid forms of (1r,2s,3r)-1-(2-(isoxazol-3-yl)-1h-imidazol-4-yl)butane-1,2,3,4-tetraol and methods of their use |
| 01/20/2010 | EP2145884A1 Indoledione derivative |
| 01/20/2010 | EP2145615A1 Skin-lightening agent containing equol compound as active ingredient |
| 01/20/2010 | EP2144934A1 Antibodies against il-25 |
| 01/20/2010 | EP2144881A1 Isoquinolinone derivatives, processes for their preparation and their use in the treatment of chronic obstructive pulmonary disease ( copd ) and asthma |
| 01/20/2010 | EP1599227B1 Methods of immunomodulation in animals |
| 01/20/2010 | EP1506214B1 6-11 bicyclic ketolide derivatives |
| 01/20/2010 | EP1458679B1 Pyrrolidine derivatives as prostaglandin modulators |
| 01/20/2010 | EP1456160B1 Vitamin d analogues |
| 01/20/2010 | EP1427396B1 Dosage forms having prolonged active ingredient release |
| 01/20/2010 | EP1202961B1 Arylsulfonamido-substituted hydroxamic acid derivatives |